RCL
Asset Logo

Readcloud Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

ReadCloud Ltd. engages in the provision of digital eLearning solutions to Australian secondary schools. The company is headquartered in Melbourne, Victoria and currently employs 500 full-time employees. The company went IPO on 2018-02-07. The firm's eBook reader delivers digital content to students and teachers with functionality, including the ability to make commentary in, and import third party content into eBooks. Students and teachers can share notes, questions, videos and weblinks directly inside the eBooks turning the eBook into a place for discussion, collaboration, and social learning. The company sources content for its solutions from multiple publishers, delivering the full Australian school curriculum in digital form in all States, on one platform. The company also provides digital vocational education and training (VET) course materials and services to schools through its subsidiaries, Australian Institute of Education and Training Unit Trust (AIET), PKY Media Pty Ltd and Ripponlea Institute Pty Ltd, which collectively offers over 60 VET courses and Auspicing services to schools across Australia.

📈 Performance

Price History

-70.50%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.06

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in RCL

2

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in RCL

518 days
RCL investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

25%

50k - 100k

25%

Less than 50k

25%
👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in RCL also invest in...

Adore Beauty Group Limited

ABY

Adore Beauty Group Ltd. operates as a marketing and e-commerce retail online beauty platform. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-10-23. The firm is an integrated content, marketing and electronic commerce retail platform that partners with beauty and personal care brands. Its product categories include skincare, make up, hair, fragrance and wellness. Its skin care products include cosmeceuticals, serums and treatments, moisturizers, cleansers, exfoliators and masks. The firm's makeup products include foundation, concealer, global shades, primer, powder, setting spray, blush and highlighters. The firm's hair products include shampoo, conditioner, scalp scrubs, dry shampoo, treatments, hair color, hair supplements, hairbrushes and tools, hair accessories, hair concern and blonde hair. Its fragrance products include home fragrance, the scent room, and fragranced hand and body care. The firm's wellness products include face sculpting tool, face roller, face mask, tongue cleaner and eye mask.

📊 Share price

$1.06 AUD

NULL AUSTRALIA

NULL TECH

NULL CONSUMER

Find Out More

Xero Ltd. engages in the provision of online business solutions for small businesses and their advisors. The firm offers a cloud-based accounting software. Its segments include Australia and New Zealand (ANZ) and International. The firm provides online business solutions for small businesses and their advisors. The features and tools of its software platform include accepting payments, bank reconciliation, pay bills, claim expenses, bank connections, tracking projects, GST returns, payroll, contact management, data capture, online file storage, reporting, inventory, multi-currency accounting, purchase orders, quotes, accounting dashboard and managing fixed assets. The company is focused on small business operational and financial needs across area beyond accounting and compliance, such as expenses, inventory management, financial services and employee services. The firm serves various industries, such as retail, high tech, non-profit, hospitality, startups and construction.

📊 Share price

$110.04 AUD

NULL TECH

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. Its principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Its other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users. The firm services over 400 hospitals.

📊 Share price

$0.10 AUD

SYI.AX was created on 2010-09-28 by SPDR. The fund's investment portfolio concentrates primarily on high dividend yield equity. The ETF currently has 385.31m in AUM and 36 holdings. The SPDR MSCI Australia Select High Dividend Yield Fund seeks to closely track, before fees and expenses, the returns of the MSCI Australia Select High Dividend Yield Index.

📊 Share price

$27.19 AUD

NULL AUSTRALIA

NULL SMART BETA

NULL ACTIVE

NULL INCOME

3P Learning Ltd. engages in the development, sale, and marketing of online educational programs. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2014-07-09. The firm is engaged in the development, sales and marketing of educational software and e-books to schools and to parents of school-aged students, which is delivered through a software-as-a-service (SaaS) subscription model. Its solutions include Mathletics, Reading Eggs, Mathseeds, and Spellodrome. Its Mathletics is the mathematics program that provides instant access to digital and physical activities for practice, fluency and thinking in one place. Its Mathseeds develops beginning numeracy skills with captivating activities covering number sense, addition, subtraction and multiplication. Its Reading Eggs is packed with e-books, activities, and resources that open the world of reading to all students. The firm's Spellodrome solution, which is built for independent learning and the development of critical spelling awareness.

📊 Share price

$1.14 AUD

Want more shares? Try these...

Rincon Resources Ltd. provides exploration and mining services. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-12-21. The firm acquires, explores, and develops commercially significant resource projects in Western Australia. The firm has a 100% interest in three copper and gold projects in Western Australia. The South Telfer Project consists of six exploration licenses and two prospecting licenses covering approximately 540 square kilometers (km2) and greater than 40 kilometers (km) strike of prospective geology known to host significant gold and copper mineralization. The Kiwirrkurra Project consists of a single granted exploration license and three exploration license applications encompassing approximately 200 km2 of the Central Australian Suture zone in the West Arunta Province of Western Australia. The Laverton Gold Project consists of two granted exploration licenses and three exploration license applications. The project area is located approximately 4 km west of the Laverton township.

📊 Share price

$0.06 AUD

Reef Casino Trust engages in the ownership and management of the Reef Hotel Casino. The company is headquartered in Brisbane, Queensland and currently employs 0 full-time employees. The Trust has investment in the Reef Hotel Casino. The Trust is the owner and lessor of the Reef Hotel Casino complex in Cairns, North Queensland, Australia. Reef Hotel Casino operates approximately 450 gaming machines, approximately 38 gambling tables, plus Club Prive, TAB, and Keno. The Pullman Reef Hotel Casino features approximately 127 luxury guest rooms and facilities swimming pool and spa, a health club, and a tour desk. The responsible entity and operator of the Trust is Reef Corporate Services Limited.

📊 Share price

$3.05 AUD

RCB.AX was created on 2012-03-08 by Russell. The fund's investment portfolio concentrates primarily on investment grade fixed income. The Fund aims to provide a total return before costs and tax, in line with DBIQ 0-4 year Investment Grade Australian Corporate Bond Index over the long term

📊 Share price

$19.57 AUD

Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-01-15. The Company’s anti-infective pipeline includes three broad-spectrum, synthetic polymer anti-infectives: RECCE 327 as an intravenous and topical therapy that is being developed for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria including their superbug forms; RECCE 435 as an orally administered therapy for bacterial infections; and RECCE 529 for viral infections. Through their multi-layered mechanisms of action, the Company’s anti-infectives have the potential to overcome the hypercellular mutation of bacteria and viruses. All RECCE compounds are 100% water soluble at all pH levels in their liquid form.

📊 Share price

$0.57 AUD
Compare
Add to watchlist